Elsevier

Experimental Eye Research

Volume 118, January 2014, Pages 117-124
Experimental Eye Research

Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye

https://doi.org/10.1016/j.exer.2013.11.011Get rights and content

Highlights

  • Interferon gamma (IFN-γ) inhibits goblet cell differentiation.

  • IFN-γ stimulates apoptosis and inhibits IL-13 signaling in the conjunctival epithelium.

  • Topically applied anti-IFN-γ inhibits apoptosis and maintains IL-13 signaling.

Abstract

Evidence suggests that the cytokine interferon (IFN)-γ released by natural killer and CD4+ T cells contributes to the conjunctival goblet cell (GC) loss in dry eye. The purpose of this study was to investigate if topical neutralization of IFN-γ prevents or alleviates GC loss in an experimental desiccating stress (DS) model of dry eye. In this study, we found that topical IFN-γ neutralization significantly decreased DS-induced conjunctival GC loss. This was accompanied by decreased epithelial apoptosis, and increased IL-13 and decreased FoxA2 expression in the forniceal conjunctiva. To establish that IFN-γ produced by pathogenic CD4+ T cells contributes to DS-induced GC loss, adoptive transfer of CD4+ T cells isolated from DS exposed donors to naïve RAG-1−/− recipient mice was performed. Similar to the donor mice, topical IFN-γ neutralization decreased conjunctival GC loss, suppressed apoptosis and increased IL-13 expression in adoptive transfer recipients. In summary, this study demonstrated that topical neutralization of IFN-γ prevents GC loss via modulating apoptosis and maintaining IL-13 signaling.

Introduction

Dry eye is one of the most prevalent eye diseases, affecting tens of millions of people worldwide. The pathogenesis of keratoconjunctivitis (KCS), the ocular surface disease of dry eye is a multifactorial process that includes activation of stress pathways in the ocular surface epithelia by desiccation, the hyperosmolar tear film and inflammatory cytokines, such as interleukin (IL)-17 and interferon gamma (IFN-γ) that are produced by resident intraepithelial lymphocytes and infiltrating CD4+ T cells (De Paiva et al., 2007, De Paiva et al., 2009, De Paiva et al., 2010, Lam et al., 2009, Niederkorn et al., 2006). Conjunctival goblet cells (GCs) are simple columnar epithelial cells that secrete the gel-forming mucin MUC5AC that stabilizes the tear film and protects the cornea. GC loss in dry eyes is often associated with a poorly protected and irregular cornea and may lead to sight-threatening corneal ulceration and perforation (Murube and Rivas, 2003, Pflugfelder et al., 1997, Stern et al., 1998a, Stern et al., 1998b). The mechanisms responsible for GC loss in KCS are not completely understood; however, there is increasing evidence indicating that an altered balance of T helper cell (Th) cytokines has a prominent role this process. We previously demonstrated that CD4+ T cells activated by exposure to desiccating stress (DS), when adoptively transferred to naïve T-cell-deficient nude mice, were sufficient to elicit autoimmune KCS with pronounced conjunctival GC loss (Niederkorn et al., 2006, Zhang et al., 2011b).

Th1 and Th2 cytokines have been found to have opposing effects on conjunctival goblet cell development. The Th2 cytokine IL-13 has been found to induce GC hyperplasia in nonocular mucosa, such as the gut and respiratory tracts (Atherton et al., 2003, Kanoh et al., 2011, Marillier et al., 2008). We have observed that IL-13 produced by resident NKT cells has a homeostatic function in promoting conjunctival epithelial goblet cell differentiation and mucus production (De Paiva et al., 2011). IL-13 signals through STAT6 and has been found to stimulate production of GC mucin MUC5AC directly or indirectly by suppressing production of the forkhead transcription factor FoxA2, a MUC5AC repressor (Kim et al., 2008, Oh et al., 2010, Rogers, 2003). In contrast, experimental desiccating stress increased the number of cells staining positively for the Th1 cytokine IFN-γ+ in the goblet cell zones of the conjunctiva and increased the concentration of IFN-γ in tears (De Paiva et al., 2007). This was accompanied by a decrease in IL-13/IFN-γ ratio and progressive GC loss. No change in conjunctival GC density was noted in IFN-γ-knockout mice subjected to desiccating stress; however, loss of GCs similar to wild type was observed following subconjunctival injection of IFN-γ in these mice (De Paiva et al., 2007). These findings suggest that strategies to neutralize IFN-γ may prevent dry eye induced GC loss.

One mechanism for IFN-γ induced GC loss in KCS is induction of conjunctival epithelial apoptosis. IFN-γ-knockout mice were found to be resistant to DS-induced conjunctival apoptosis; however, exogenous administration of IFN-γ to this strain significantly increased apoptosis after DS (Zhang et al., 2011a). Meaningfully, apoptosis was greatest in the goblet cell area, and MUC5AC expression was inversely associated with level of apoptosis in experimental murine dry eye, suggesting that IFN-γ may cause GC loss in DS by promoting apoptosis under DS (Zhang et al., 2011a).

The purpose of this study was to investigate if topical neutralization of IFN-γ would alleviate or prevent GC loss by maintaining IL-13 expression and modulating apoptosis using a murine DS model with features similar to human KCS.

Section snippets

Mouse model of dry eye

This research protocol was approved by the Baylor College of Medicine Center for Comparative Medicine, and it conformed to the standards in the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

Desiccating stress (DS) was used to induce experimental dry eye in C57/BL6(B6) mice, 6–8 weeks of age of both genders, by subcutaneous injection of 0.5 mg/0.2 mL scopolamine hydrobromide (Sigma–Aldrich, St. Louis, MO) into alternating hindquarters administered four times a day (8:30

Topical IFN-γ neutralization inhibits conjunctival GC loss in a DS model of dry eye

To investigate the role of IFN-γ neutralization in preventing conjunctival GC loss in dry eye, we used B6 mice to evaluate if topical IFN-γ neutralization minimizes or prevents DS-induced conjunctival GC loss. We found that topical IFN-γ neutralization significantly decreased DS-induced conjunctival GC loss. We previously found a significant inverse correlation between the density of infiltrating CD4+ T cells and GCs and this was associated with a decreased IL-13/IFN-γ ratio (De Paiva et al.,

Discussion

This study demonstrated that topical neutralization of IFN-γ could prevent conjunctival GC loss in a desiccating stress model of dry eye and following adoptive transfer of DS-elicited CD4+ T cells. These cells synthesize, store, and secrete the large gel-forming mucin MUC5AC that lubricates and protects the ocular surface. Decrease or loss of mucin-filled GCs is a well-recognized feature of aqueous deficient dry eye (Dursun et al., 2002, Hori et al., 2006, Stern et al., 1998a, Stern et al.,

Financial support

NIH Grant EY11915 (SCP), NEI/NIH core Grant for Vision Research EY-002520-37, an unrestricted grant from Research to Prevent Blindness, New York, NY (SCP), the Oshman Foundation, Houston, TX (SCP), the William Stamps Farish Fund, Houston, TX (SCP), Hamill Foundation, Houston, TX (SCP).

Financial disclosures

The authors have no proprietary interest in any materials or methods described within this article.

References (26)

  • G.E. Grau et al.

    Monoclonal antibody against inferferon-γ can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

    Proc. Natl. Acad. Sci.

    (1989)
  • Y. Hori et al.

    Mucins and contact lens wear

    Cornea

    (2006)
  • S. Kanoh et al.

    IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells

    Clin. Exp. Allergy

    (2011)
  • Cited by (67)

    • Cell identity changes in ocular surface Epithelia

      2023, Progress in Retinal and Eye Research
      Citation Excerpt :

      However, conclusive evidence supporting its efficacy in treating LSCD as a sole intervention, i.e., without limbal tissue or LESC integration, is still lacking (Sabater and Perez, 2017; Le and Deng, 2019). SQM is perhaps best characterized in cicatrizing ocular surface diseases (de Paiva et al., 2007; Li et al., 2010b; Chen et al., 2009b, 2010; Zhang et al., 2014) where it has been specifically targeted with tear substitutes (Aquilar et al., 2018) and a myriad of pharmacological interventions (He et al., 2020; Simsek et al., 2019; Wang et al., 2008; Tseng, 1985b; Herbort et al., 1988). The principal objective being to reduce inflammation, stabilize conjunctival GC density and improve mucosal function.

    • Modulation of ocular surface desiccation in a murine model by histatin-5 application

      2023, Ocular Surface
      Citation Excerpt :

      Moreover, reduction of inflammation and immune cell infiltration have been associated with preservation of GC populations in models of DED [13], and is also observed in our study. While not certain, it is possible that the preservation of GCs seen in this study under stressed conditions in Hst5 treated mice is related to immune signaling changes, such as reductions of IFN-γ, that have been seen with other therapeutics tested in dry eye models [13,15,55]. While these findings are exciting and point to the potential of Hst peptides as new agents in the armamentarium of treatment for ocular surface diseases, limitations of this study should be carefully noted.

    • Sex and age differences in symptoms and signs of dry eye disease in a Norwegian cohort of patients

      2021, Ocular Surface
      Citation Excerpt :

      In turn, hyperosmolarity causes inflammatory responses in the cornea, characterized by the release of inflammatory mediators such as interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and matrix metalloproteinases [27,34,35]. In addition, IFN-γ can reduce goblet cell proliferation, resulting in the vicious cycle of DED [36–38]. Goblet cells and their secreted mucins are crucial for corneal protection and wettability [39,40].

    • Ocular mucins in dry eye disease

      2019, Experimental Eye Research
    View all citing articles on Scopus
    View full text